Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF vs Hyaluronic Acid for Knee Osteoarthritis
NCT02039531Phase 3Completed
- Start
- Aug 2011
- Primary completion
- Feb 2013
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of PRGF-Endoret in knee osteoarthritis (OA). Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 6 months. Started Aug 2011; status: completed.
02
Drugs
PRGF-Endoret
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02039531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039531.